register

Medical and Science

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

Health Industry Hub | September 6, 2024 |

Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes Pearson and Cheyne Sullivan. Supported by Pfizer Australia, this initiative aims to cultivate leadership skills through international and cross-cultural experiences.

Jes Pearson and Cheyne Sullivan will embark on an international journey to exchange experiences, gain knowledge, and foster leadership capabilities. They will engage with Indigenous pharmacist representatives globally, building networks and identifying effective strategies to bring back to Australia.

Dr Dawn Casey, Deputy CEO of NACCHO, stated “We are thrilled to see the calibre of upcoming Aboriginal and Torres Strait Islander pharmacy leaders. Congratulations to the winners and all applicants for their initiative and commitment. Developing our pharmacy workforce is crucial for improving cultural safety and accessibility.”

Cheyne Sullivan, a Barkindji woman and SA Pharmacy Aboriginal Health and Beyond the Gap Project Lead, shared her excitement, saying “Winning the grant will provide a global perspective on medicines management for Indigenous peoples. I look forward to applying these insights to my work and fostering collaboration.”

The integral role of First Nations pharmacists: NACCHO and Pfizer leaders address the complex gap

Jes Pearson, a Wiradjuri woman, reflected on the grant’s impact. She said “Growing up, I struggled with opportunities to discover my culture and career prospects. This grant will broaden my perspective and help improve Indigenous healthcare.”

Anne Harris, Managing Director of Pfizer Australia & New Zealand, highlighted the initiative’s importance.

“Developing and supporting Aboriginal and Torres Strait Islander healthcare professionals is vital for the provision of culturally appropriate care. At Pfizer, we recognise how important this is in achieving equitable health outcomes for First Nations communities. Congratulations Jes and Cheyne – we’re excited to contribute to your professional growth and leadership in pharmacy,” she said.

Leigh Simmonds, Senior Manager Patient Advocacy at Pfizer, emphasized the company’s commitment to health equity and workforce development.

“We have been on a journey of reconciliation. Through listening and learning, we have come to a greater understanding of the interconnectedness of culture, language, Country, and Aboriginal world views of health and wellbeing. We recognise the importance of health workforce development.

“Support for this leadership grant is just one aspect of our overall commitment to improving health equity for generations to come.”

This initiative not only builds future leaders but also addresses the underrepresentation of Aboriginal and Torres Strait Islander pharmacists in Australia, promoting visibility and leadership within the profession.

The grant, funded by Pfizer Australia, includes up to $15,000 for travel and accommodation per recipient, further supporting their development.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Health Industry Hub | October 11, 2024 |

Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]

More


News & Trends - Pharmaceuticals

New CVD model marks a critical step in the right direction

New CVD model marks a critical step in the right direction

Health Industry Hub | October 11, 2024 |

Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]

More


News & Trends - Pharmaceuticals

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Health Industry Hub | October 11, 2024 |

Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]

More


Leadership & Management

J&J MedTech appoints new ANZ leader

J&J MedTech appoints new ANZ leader

Health Industry Hub | October 10, 2024 |

Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]

More


This content is copyright protected. Please subscribe to gain access.